Business Description
Kennametal Inc. is a global leader in developing and applying cutting-edge materials, including tungsten carbides, ceramics, and super-hard compounds. Their core mission is to provide robust solutions for demanding industrial applications, specifically in metal cutting and environments prone to extreme wear, high temperatures, and corrosion, serving clients worldwide. The company's operations are structured into two primary segments: Metal Cutting and Infrastructure. Within the Metal Cutting division, Kennametal offers a comprehensive portfolio of standard and bespoke products, encompassing tools for turning, milling, and hole-making, integrated tooling systems, and associated technical services. They also supply specialized wear-resistant components and advanced metallurgical powders. These critical products serve a diverse array of manufacturers across industries such as transportation (vehicles and components), machine tools, light and heavy machinery, aerospace (airframes and components), and the energy sector (oil and gas, power generation). The company further supports these clients with expert product design, selection, application guidance, and ongoing support services, delivering customized metal cutting solutions. Under its Infrastructure segment, Kennametal produces a variety of specialized items. This includes compacts, nozzles, frac seats, and tailored components crucial for the oil and gas and petrochemical industries. They also provide rod blanks and abrasive water jet nozzles for broader industrial applications, alongside durable earth-cutting tools and systems essential for underground mining, trenching, foundation drilling, and road milling. Furthermore, the company manufactures tungsten carbide powders for aerospace, oil and gas, and process industries, as well as ceramics specifically utilized by the packaging industry for film and paper metallization. Kennametal's extensive product lines are marketed under well-known brands such as Kennametal, WIDIA, WIDIA Hanita, and WIDIA GTD. Distribution occurs through a multi-channel approach, leveraging a direct sales force, a broad network of independent and national distributors, integrated supplier relationships, and online platforms. Founded in Pittsburgh, Pennsylvania, in 1938, the company boasts a long-standing history in the industrial materials sector.
Business History
Generated: Jun 17, 2026 3:02amPrice Overview
Last updated: Jun 17, 2026 3:00am (10d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.21
Total Equity: $1.28B
Shares: 77,894,000
Total Debt: $597.77M
Cash: $140.54M
EBITDA: $293.43M
Total Debt: $597.77M
Cash: $140.54M
Revenue: $1.97B
Revenue: $1.97B
Revenue: $1.97B
Total Equity: $1.28B
Tax Rate: 25.2%
Equity: $1.28B
Total Debt: $597.77M
Cash: $140.54M
Current Liabilities: $422.33M
Long-Term Debt: $596.79M
Total Debt: $597.77M
Total Equity: $1.28B
Shares: 77,894,000
Shares: 77,894,000
CapEx: -$88.97M
Shares: 77,894,000
Stock Price: $36.50
Net Income: $93.13M
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
Kennametal is a mature industrial earner with genuinely high-quality accounting: OCF/NI of 2.51x, negative accruals (-5% of assets), Beneish M at -2.69 and Altman Z at 3.28 all point to real, conservatively-stated earnings. FCF has averaged ~$130M/yr across the last five years ($119M in 2025), comfortably funding the dividend and a buyback that has shrunk diluted shares from 84.3M to 77.9M (a ~2%/yr CAGR) while SBC is a modest 1.1% of revenue and buybacks run 223% of SBC — per-share value is being concentrated, not leaked.
The concern is the operating trajectory. Revenue peaked at $2.08B in 2023 and has slid two years in a row to $1.97B in 2025. Gross margin has drifted from 32.2% (2022) to 30.4%, and — more telling — operating margin has compressed every single year from 10.8% (2022) → 9.3% → 8.3% → 7.3%, with net income falling from $144.6M to $93.1M. That is a clear loss of operating leverage in a cyclical, late-cycle short-cycle industrial. The balance sheet is workable but not a cushion: net debt of $457M against $140M cash means leverage matters if the down-cycle deepens, though Altman Z of 3.28 says solvency is not in question.
Insider tape is one-sided sell (7 sales, 0 buys, $4.8M) across multiple officers (Patel, Reilly, Keating, Witt, Bacchus) — consistent with a mature comp structure but notable given the deteriorating margin trend; no insider is leaning in.
Verify before trusting this (6)
- Segment-level revenue/margin split (Metal Cutting vs Infrastructure) to see whether the OpM compression is mix, volume, or pricing.
- End-market exposure (oil & gas, aerospace, general engineering) and whether the revenue decline is share loss or cyclical.
- Debt maturity ladder and covenants on the $457M net debt position.
- Restructuring/'modernization' charges in 2024–25 — are reported OpMs depressed by one-timers that should reverse?
- Whether buyback pace is being maintained into the margin downturn or being throttled to protect the balance sheet.
- 10b5-1 plan disclosures behind the insider sales to gauge whether selling is programmatic or discretionary.
The composite fair value comes in at $16.84 (signal-adjusted $15.64), with DCF at $17.38 and an EPV floor at $15.76 — a tight cluster, not a runaway method. Against a $36.50 price that implies the market is paying ~2.2× deserved value, or about -57% downside to fair. Even if I generously haircut these as too conservative (EPV assumes no growth; DCF likely uses depressed near-term FCF), getting to $36.50 requires either a meaningful margin re-rate back toward prior peaks or a multi-year capex super-cycle — neither of which is in evidence given four straight years of operating margin compression and two years of revenue decline.
Quality is Solid (8/10) and earnings quality is high, which earns deserved value some uplift over EPV — call it $20-24 on a charitable view that normalized FCF is higher than trailing. That still leaves the stock ~50-80% above what I'd defend. The bull case (cycle recovery, IP-driven re-rate) is plausible but is exactly what's already priced in; the bear case (commodity tooling, China, secular tool consolidation) is not.
This isn't a screaming short — clean books, buybacks, and a real franchise create a floor — but at $36.50 you are buying optionality on a cyclical recovery at a full multiple. No margin of safety.
Verify before trusting this (5)
- FY guidance for organic revenue and operating margin — is the four-year margin slide bottoming?
- Segment-level pricing vs volume to see if Chinese competition is showing in mix
- Normalized FCF after stripping any one-off restructuring/working-capital items — recompute EPV on that
- Buyback pace and any debt paydown — capital return supports floor but doesn't justify multiple
- Order book / book-to-bill commentary as a real-time cycle tell
KMT sits in an awkward sentiment spot: the active narrative is a 'fallen-angel' industrial with only moderate intensity and explicitly fragile durability, meaning there is no cult bid to defend the stock when the tape wobbles. The bull case requires a manufacturing capex re-acceleration the market is not currently underwriting, while the bear case (China competition, tool consolidation, mean reversion) is the easier story to tell in a neutral regime with the 10y at 4.43% and VIX elevated versus its own year. At beta 1.37 in a Manufacturing - Tools sub-industry that screens as cyclical and unloved, even a flat tape lands harder here than on a defensive compounder. Analyst tone is the clearest tell: consensus is a sleepy Hold, targets ($35.75) sit essentially at spot, and the two revisions this month averaged $33.50 - downward drift, not capitulation, but the direction is wrong and diverges from the bullish 're-rate' narrative. Combined with negative price momentum (-2.7% CAGR) and weakening cash generation in the recent flow, the non-fundamental pressure leans headwind: nothing is actively pushing this name up, and several small forces are pushing it down.
Verify before trusting this (5)
- Whether sell-side revisions continue to drift down through next quarter or stabilize
- Any rotation into industrial cyclicals tied to ISM or capex data prints
- VIX behavior - a move back below 15 would soften the high-beta drag
- Headlines on China tooling pricing or automation displacement that could harden the bear narrative
- Whether the 10y breaks below 4.2%, which would relieve rate pressure on the capex bull case
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 17, 2026 3:05am (10d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.0B | $2.1B | $2.0B | $2.0B |
| Cost of Revenue | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B |
| Gross Profit | $552.5M | $648.0M | $646.4M | $627.1M | $598.1M |
| Operating Expenses | $450.3M | $429.8M | $454.0M | $456.9M | $454.9M |
| Operating Income | $102.2M | $218.1M | $192.4M | $170.2M | $143.1M |
| Net Income | $54.4M | $144.6M | $118.5M | $109.3M | $93.1M |
| EBITDA | $237.5M | $364.3M | $322.1M | $305.6M | $293.4M |
| EPS | $0.65 | $1.74 | $1.47 | $1.38 | $1.21 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 17, 2026 3:00am (10d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $154.0M | $85.6M | $106.0M | $128.0M | $140.5M |
| Total Current Assets | $1.0B | $1.0B | $1.0B | $1.0B | $1.0B |
| Total Assets | $2.7B | $2.6B | $2.5B | $2.5B | $2.5B |
| Current Liabilities | $437.4M | $485.6M | $434.0M | $416.0M | $422.3M |
| Long-Term Debt | $592.1M | $594.4M | $595.2M | $596.0M | $596.8M |
| Total Liabilities | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B |
| Total Equity | $1.3B | $1.3B | $1.3B | $1.2B | $1.3B |
| Retained Earnings | $992.6M | $1.1B | $1.1B | $1.2B | $1.2B |
Cash Flow (Annual)
Last updated: Jun 17, 2026 3:05am (10d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $235.7M | $181.4M | $257.9M | $277.1M | $208.3M |
| Capital Expenditure | -$127.3M | -$96.9M | -$94.4M | -$107.6M | -$89.0M |
| Free Cash Flow | $108.4M | $84.5M | $163.6M | $169.5M | $119.4M |
| Acquisitions (net) | $0 | $1.0M | $0 | -$4.0M | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $-197,000 | -$85.5M | -$49.3M | -$65.6M | -$60.1M |
| Net Change in Cash | -$452.6M | -$68.5M | $20.4M | $22.0M | $12.6M |
Analyst Estimates (Annual)
Last updated: Jun 17, 2026 3:00am (10d ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$2.3B $2.3B – $2.5B
|
$2.7B $2.6B – $2.8B
|
$2.7B $2.7B – $2.7B
|
$2.6B $2.5B – $2.7B
|
| EBITDA |
$358.5M $347.2M – $375.3M
|
$409.8M $397.2M – $420.8M
|
$413.4M $413.4M – $413.4M
|
$393.2M $380.8M – $411.6M
|
| Net Income |
$297.1M $117.1M – $399.3M
|
$344.8M $101.9M – $482.5M
|
$180.1M $148.3M – $218.6M
|
$218.3M $209.3M – $231.6M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 17, 2026 3:05am (10d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +9.3% | +3.3% | -1.5% | -3.9% |
| Gross Profit Growth | +17.3% | -0.2% | -3.0% | -4.6% |
| Operating Income Growth | +113.5% | -11.8% | -11.5% | -15.9% |
| Net Income Growth | +165.7% | -18.1% | -7.7% | -14.8% |
| EBITDA Growth | +53.4% | -11.6% | -5.1% | -4.0% |
Insider Trading (Recent)
Last updated: Jun 17, 2026 3:04am (10d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Bacchus Judith L | S-Sale | 5,488.00 | $35.94 | $197,239 |
| 2026-06-08 | Patel Sagar A | S-Sale | 29,498.61 | $33.50 | $988,203 |
| 2026-06-02 | Reilly Carlonda R. | S-Sale | 12,013.00 | $33.12 | $397,907 |
| 2026-05-26 | DIETRICH DOUGLAS T | A-Award | 697.08 | $0.00 | $0 |
| 2026-05-26 | Bausch Shelley J | A-Award | 575.26 | $0.00 | $0 |
| 2026-03-09 | Reilly Carlonda R. | S-Sale | 13,410.00 | $36.31 | $486,971 |
| 2026-03-09 | Reilly Carlonda R. | G-Gift | 1,590.00 | $0.00 | $0 |
| 2026-02-24 | DIETRICH DOUGLAS T | A-Award | 642.15 | $0.00 | $0 |
| 2026-02-24 | Bausch Shelley J | A-Award | 529.93 | $0.00 | $0 |
| 2026-02-19 | Witt John Wayne | S-Sale | 5,060.00 | $38.29 | $193,737 |
| 2026-02-18 | LAMBERT WILLIAM M | M-Exempt | 14,000.00 | $20.87 | $292,180 |
| 2026-02-18 | LAMBERT WILLIAM M | F-InKind | 7,485.00 | $39.04 | $292,214 |
| 2026-02-18 | LAMBERT WILLIAM M | M-Exempt | 14,000.00 | $20.97 | $293,580 |
| 2026-02-18 | Reilly Carlonda R. | G-Gift | 2,500.00 | $0.00 | $0 |
| 2026-02-11 | Keating Michelle R | S-Sale | 24,617.00 | $40.22 | $990,194 |
| 2026-02-11 | Bacchus Judith L | S-Sale | 39,051.00 | $40.23 | $1.6M |
| 2026-01-30 | DIETRICH DOUGLAS T | M-Exempt | 841.00 | $0.00 | $0 |
| 2026-01-30 | DIETRICH DOUGLAS T | M-Exempt | 841.00 | $34.39 | $28,922 |
| 2026-01-30 | DIETRICH DOUGLAS T | F-InKind | 25.00 | $34.39 | $860 |
| 2026-01-15 | Sternlieb Paul | M-Exempt | 885.00 | $34.56 | $30,586 |
Dividend History (Last 20)
Last updated: Jun 17, 2026 3:00am (10d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-12 | $0.20 | 2026-04-28 | 2026-05-12 | 2026-05-26 |
| 2026-02-10 | $0.20 | 2026-01-27 | 2026-02-10 | 2026-02-24 |
| 2025-11-10 | $0.20 | 2025-10-28 | 2025-11-10 | 2025-11-24 |
| 2025-08-12 | $0.20 | 2025-07-29 | 2025-08-12 | 2025-08-26 |
| 2025-05-13 | $0.20 | 2025-05-01 | 2025-05-13 | 2025-05-27 |
| 2025-02-11 | $0.20 | 2025-01-28 | 2025-02-11 | 2025-02-25 |
| 2024-11-12 | $0.20 | 2024-10-29 | 2024-11-12 | 2024-11-26 |
| 2024-08-13 | $0.20 | 2024-07-30 | 2024-08-13 | 2024-08-27 |
| 2024-05-13 | $0.20 | 2024-04-30 | 2024-05-14 | 2024-05-28 |
| 2024-02-12 | $0.20 | 2024-01-30 | 2024-02-13 | 2024-02-27 |
| 2023-11-06 | $0.20 | 2023-10-24 | 2023-11-07 | 2023-11-21 |
| 2023-08-07 | $0.20 | 2023-08-01 | 2023-08-08 | 2023-08-22 |
| 2023-05-08 | $0.20 | 2023-05-01 | 2023-05-09 | 2023-05-23 |
| 2023-02-13 | $0.20 | 2023-02-06 | 2023-02-14 | 2023-02-28 |
| 2022-11-07 | $0.20 | 2022-10-31 | 2022-11-08 | 2022-11-22 |
| 2022-08-08 | $0.20 | 2022-08-01 | 2022-08-09 | 2022-08-23 |
| 2022-05-09 | $0.20 | 2022-05-02 | 2022-05-10 | 2022-05-24 |
| 2022-02-14 | $0.20 | 2022-02-07 | 2022-02-15 | 2022-03-01 |
| 2021-11-08 | $0.20 | 2021-11-01 | 2021-11-09 | 2021-11-23 |
| 2021-08-09 | $0.20 | 2021-08-02 | 2021-08-10 | 2021-08-24 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
The raw quarterly tape tells a very different story than the synthesis verdict acknowledges. Revenue went from $482M in Sep-24 to $592.6M in Mar-26 — that's +23% over six quarters, with net income going from $17.9M (Dec-24) to $58.2M (Mar-26), a 3.25x jump. Net margin expanded from 3.7% to 9.8% sequentially across the last four prints. This is not a "structurally challenged industrial losing share" — this is a cyclical inflecting hard off a trough. The trailing-twelve-month revenue is now ~$2.14B (vs. FY2025's $1.97B), and TTM net income annualized off the recent run-rate is approaching $140-150M, which would put forward P/E closer to 18-19x on depressed-but-recovering earnings, not the headline 20x on stale TTM.
The Market Forces and Synthesis modules appear to be anchored on the FY2021-FY2025 annual decline (rev $2.08B → $1.97B, NI $118M → $93M) and the trailing CAGRs (-2.7% rev, -11.3% earnings), which entirely miss the recent quarterly turn. A $15.64 DCF fair value implies KMT earns ~$50-60M sustainably forever — but they just printed $58M in a single quarter. The DCF is using trough inputs as terminal assumptions, which is a classic late-cycle valuation error on cyclicals. Meanwhile the Pre-Flight thesis actually got it right by flagging "60% drawdown prices in prolonged downturn with no recovery catalyst" — except the Mar-26 print IS the catalyst, and the models seem not to have integrated it. The Narrative layer's "fallen angel/fragile" framing is internally inconsistent with the secondary signal flagging "Revenue Confidence: accelerating."
The contrarian case against my read: (1) the Mar-26 quarter could be a one-off pulled forward by tariff/inventory dynamics — industrial distributors stocking ahead of trade actions is a real phenomenon in 2025-26; (2) insider activity is unambiguously bearish — six sales and zero open-market buys over four months, with sales accelerating in June 2026 right after the strong print, which is exactly when insiders would dump into strength if they didn't believe it was durable; (3) gross margin at 30.4% is still well below the FY2022 peak (~32.3%), and operating margin at 7.3% trails the 10.8% peak — so "margin recovery" has room but isn't proven sustainable; (4) FCF of $119M on FY2025 supports the 3.49% dividend but barely — payout is tight, and capex of $89M is not discretionary in a tooling business. The balance sheet tile is missing total debt entirely, which is a real gap — KMT historically runs ~$600M net debt, and at 9.3x EV/EBITDA that's already reflected, but I can't verify leverage trajectory from this file.
I dissent from the synthesis "overvalued at $15.64 fair value" verdict — that number is absurd given a company generating $58M quarterly net income and $208M annual OCF. I also dissent from Market Forces' "structurally challenged, avoid" — the accelerating quarterly trajectory contradicts the structural-decline thesis directly. But I won't go full bull either: the insider selling cluster is a genuine yellow flag, the cyclical recovery may be tariff-distorted, and at $36.50 you're paying ~1x sales and 9.3x EV/EBITDA for a business whose normalized earnings power is genuinely uncertain between $90M (FY2025 actual) and $200M (annualized recent run-rate). Fair value on mid-cycle earnings of ~$130-140M at a 15x multiple lands around $24-28/share; on the optimistic run-rate it's $40-45. Current price splits the difference reasonably. The prior models' $15-17 fair value is mechanically wrong because they're extrapolating decay through an inflection.
GPT Critique
Kennametal Inc.'s recent performance signals a noteworthy turnaround that contrasts sharply with its past metrics. The company experienced a significant revenue increase from $482 million in September 2024 to $592.6 million by March 2026, marking a 23% rise over six quarters. Concurrently, net income jumped from $17.9 million in December 2024 to $58.2 million in March 2026, reflecting a compelling 3.25x increase. This resulted in a net margin uplift from 3.7% to 9.8%. These figures suggest a robust recovery from what seemed a cyclical bottom, contrary to the narrative of a "structurally challenged" firm. Furthermore, the trailing twelve-month revenue approximates $2.14 billion, exceeding the fiscal year 2025's $1.97 billion, indicating a positive growth trajectory.
I agree with Opus's contention that the synthesis verdict's overvaluation claim, pegging fair value at $15.64, is based on outdated assumptions. The quarter ending in March 2026 provides evidence of a substantial earnings rebound, which isn't accounted for in the synthesis model's conservative projections. Opus correctly identifies the outdated nature of using a $15.64 DCF fair value, which assumes perpetual earnings of $50-60 million, a figure that the company surpassed in the latest quarter alone. However, I diverge slightly from Opus's valuation optimism. While they suggest a fair range of $26-40, I am more cautious, noting that insider selling and potential tariff impacts could temper this recovery's durability.
Opus highlights insider selling as a critical concern, which I share. The recent spate of insider sales, particularly following the strong March 2026 quarterly results, raises questions about management's confidence in sustaining this recovery. Additionally, while gross margins have improved to 30.4%, they remain below the FY2022 peak of 32.3%, indicating room for improvement but also potential volatility. The absence of total debt figures in the balance sheet is a notable gap, considering Kennametal's historical net debt position near $600 million, which could influence financial flexibility and risk assessment.
A careful skeptic might argue that the recent quarterly improvements could be anomalies rather than the start of a sustained trend. The uptick might be attributed to temporary factors like inventory adjustments ahead of trade actions, which are prevalent in the current industrial climate. Furthermore, although the current price of $36.50 reflects a midpoint between potential earnings scenarios, the lack of clarity on long-term earnings stability introduces significant risk, particularly if macroeconomic conditions deteriorate.